Brokerages Set Iqvia Holdings Inc (IQV) Price Target at $110.40

Iqvia Holdings Inc (NYSE:IQV) has been given an average rating of “Buy” by the twenty-two analysts that are currently covering the firm, MarketBeat.com reports. Eight analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $110.40.

Several equities research analysts recently issued reports on the company. Zacks Investment Research upgraded Iqvia from a “sell” rating to a “hold” rating in a report on Wednesday, April 18th. Argus lifted their price objective on Iqvia from $110.00 to $112.00 and gave the stock a “buy” rating in a report on Monday, April 9th. ValuEngine cut Iqvia from a “buy” rating to a “hold” rating in a report on Tuesday, April 3rd. Goldman Sachs upgraded Iqvia from a “neutral” rating to a “buy” rating in a report on Friday, April 13th. Finally, Mizuho set a $97.00 target price on Iqvia and gave the stock a “hold” rating in a report on Wednesday, January 24th.

How to Become a New Pot Stock Millionaire

Shares of Iqvia stock traded up $1.73 on Wednesday, hitting $99.00. The company’s stock had a trading volume of 137,800 shares, compared to its average volume of 1,059,663. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 1.21. Iqvia has a 1 year low of $81.43 and a 1 year high of $110.67. The firm has a market cap of $20,258.43, a PE ratio of 22.54, a P/E/G ratio of 1.65 and a beta of 0.63.

Iqvia (NYSE:IQV) last posted its quarterly earnings data on Wednesday, February 14th. The medical research company reported $1.32 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.34 by ($0.02). Iqvia had a return on equity of 13.03% and a net margin of 13.44%. The firm had revenue of $2.16 billion during the quarter, compared to analyst estimates of $2.14 billion. During the same quarter in the previous year, the firm posted $1.09 earnings per share. The company’s quarterly revenue was up 10.7% on a year-over-year basis. sell-side analysts expect that Iqvia will post 5.02 EPS for the current year.

In other news, insider Robert Parks sold 896 shares of Iqvia stock in a transaction that occurred on Thursday, March 15th. The shares were sold at an average price of $105.73, for a total transaction of $94,734.08. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider James H. Erlinger III sold 10,000 shares of Iqvia stock in a transaction that occurred on Monday, February 26th. The shares were sold at an average price of $100.00, for a total transaction of $1,000,000.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 12,527 shares of company stock worth $1,257,834. Corporate insiders own 6.00% of the company’s stock.

Several hedge funds have recently added to or reduced their stakes in the company. Winslow Evans & Crocker Inc. purchased a new stake in Iqvia in the fourth quarter valued at approximately $123,000. Focused Wealth Management Inc purchased a new stake in Iqvia in the fourth quarter valued at approximately $166,000. Valeo Financial Advisors LLC purchased a new stake in Iqvia in the fourth quarter valued at approximately $170,000. IFP Advisors Inc purchased a new stake in Iqvia in the fourth quarter valued at approximately $200,000. Finally, Livforsakringsbolaget Skandia Omsesidigt purchased a new stake in Iqvia in the fourth quarter valued at approximately $209,000. 92.58% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: “Brokerages Set Iqvia Holdings Inc (IQV) Price Target at $110.40” was posted by Week Herald and is the sole property of of Week Herald. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of United States & international copyright laws. The original version of this piece of content can be read at https://weekherald.com/2018/04/23/brokerages-set-iqvia-holdings-inc-iqv-price-target-at-110-40.html.

Iqvia Company Profile

IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Analyst Recommendations for Iqvia (NYSE:IQV)

Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply